Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Steric-Blocking ASO Synthesis

High-affinity, non-cleaving antisense oligonucleotide synthesis for functional RNA control. Bio-Synthesis specializes in steric-blocking ASO designs using PNA, PMO, TMO / Tricyclo-DNA analogs, and advanced ASO chemistries for translation blocking, RNA-protein inhibition, splice modulation, and research or development workflows.

PNA Steric Blockers PMO / Morpholino TMO / Tricyclo-DNA Analogs Advanced ASO Chemistry 100 g/batch ISO 9001:2015 / ISO 13485:2016 U.S. Facilities - Texas
Request a Quote Speak to a Scientist
Talk to a chemist Request a quote
Overview Mechanism of action PNA / PMO / TMO ASO comparison Advanced chemistry Applications Synthesis options Add-ons FAQ Contact

Steric-Blocking ASO Overview

Steric-blocking antisense oligonucleotides (ASOs) are designed to bind target RNA without inducing RNA cleavage. Instead of recruiting RNase H, these ASOs physically block RNA function by preventing ribosome access, disrupting RNA-protein interactions, inhibiting regulatory RNA activity, or redirecting splice-site recognition.

Bio-Synthesis offers custom steric-blocking ASO synthesis with specialized expertise in PNA, PMO, and TMO / Tricyclo-DNA and related advanced analog chemistries. These fully modified ASO platforms are especially useful when the goal is to control RNA function without destroying the RNA transcript.

With advanced oligonucleotide chemistry capabilities, ISO-certified quality systems, and U.S.-based manufacturing facilities in Texas, Bio-Synthesis supports steric-blocking ASO projects from discovery-scale screening through development-scale production up to 100 g/batch, depending on sequence, chemistry, and QC requirements.

Best-fit use: Choose steric-blocking ASOs when you need precise RNA functional control without RNA degradation, especially for translation blocking, RNA-protein interaction inhibition, splice modulation, or miRNA/regulatory RNA targeting.

Steric-Blocking ASO Mechanism of Action

Steric-blocking ASOs are typically fully modified to maintain high binding affinity and nuclease resistance while avoiding RNase H activation. Their activity depends on target accessibility, ASO chemistry, sequence specificity, and the biological process being blocked.

Steric-Blocking ASO Mechanism and Chemistry Expertise

Steric-blocking antisense oligonucleotide mechanism using PNA, PMO, and TMO chemistries for translation blocking, splice modulation, and RNA-protein inhibition

Steric-blocking ASO overview. Fully modified ASOs bind target RNA without RNase H cleavage, enabling translation blocking, RNA-protein interaction inhibition, splice modulation, and regulatory RNA targeting.

Steric-Blocking ASO Design Recommendations

Steric-blocking ASO design depends on selecting an accessible RNA region, choosing a fully modified non-cleaving chemistry, and matching the oligonucleotide design to the intended mechanism such as translation blocking, splice modulation, RNA-protein inhibition, or regulatory RNA targeting.

General Design Guidelines

  • Use fully modified ASO designs that do not recruit RNase H
  • Prioritize accessible RNA regions near the functional site being blocked
  • Typical steric-blocking ASOs often range from 15–30 nucleotides depending on chemistry
  • Evaluate GC balance, sequence specificity, and predicted secondary structure
  • Avoid strong self-complementarity, long homopolymer runs, and nonspecific binding motifs
  • Confirm whether the goal is translation blocking, splice modulation, miRNA inhibition, or RNA-protein interaction blocking

Target Region Selection

  • For translation blocking, target the 5′ UTR, start codon region, or ribosome-accessible sequence
  • For splice modulation, target splice donor sites, acceptor sites, branch points, or regulatory splice elements
  • For RNA-protein blocking, target the known protein-binding motif or structured RNA element
  • For miRNA inhibition, target the mature miRNA sequence or key seed-region interactions
  • Review transcript isoforms and species homology when designing for translational studies
  • Use multiple candidate ASOs when RNA accessibility is uncertain

Chemistry Selection

  • PNA supports very high-affinity binding and strong sequence specificity
  • PMO is widely used for steric-blocking and splice-switching applications
  • TMO / Tricyclo-DNA analogs support high-affinity designs for specialized RNA targets
  • 2′-OMe and 2′-MOE chemistries can support non-cleaving RNA modulation
  • LNA, BNA, and cEt modifications may improve affinity but require careful placement
  • Conjugates such as peptides, lipids, or targeting ligands may improve delivery or uptake

Bio-Synthesis Design Support

  • Custom steric-blocking ASO synthesis using PNA, PMO, TMO, 2′-OMe, 2′-MOE, LNA, BNA, and related chemistries
  • Support for fully modified non-cleaving ASO designs
  • Custom conjugation, labeling, purification, and QC workflows
  • Scale-up support for research, translational, and preclinical oligonucleotide programs
  • Specialized chemistry support for challenging RNA targets
  • Documentation and analytical characterization options based on project needs
Design note: Steric-blocking ASOs are best suited for functional RNA modulation without transcript degradation. Successful design depends on RNA accessibility, target-site selection, chemistry choice, binding affinity, and the biological process being blocked.

Leading Steric-Blocking ASO Chemistries: PNA, PMO & TMO

PNA (Peptide Nucleic Acid)

PNA-based ASOs use a neutral peptide-like backbone that provides very high affinity and sequence specificity for RNA and DNA targets.

  • Neutral peptide-like backbone
  • Extremely high binding affinity
  • Excellent stability and specificity
  • Useful for RNA blocking, diagnostics, and research applications
Explore PNA Synthesis →

PMO (Morpholino)

PMO ASOs use a morpholino backbone and are widely used for non-cleaving RNA modulation, splice switching, and exon-skipping workflows.

  • Neutral morpholino backbone
  • Does not activate RNase H
  • Highly stable in biological systems
  • Gold standard for splice modulation and exon skipping
Explore PMO (Morpholino) Synthesis →

TMO / Tricyclo-DNA & Advanced Analogs

TMO / Tricyclo-DNA and constrained analog chemistries support high-affinity steric-blocking designs for challenging RNA targets.

  • Constrained backbone structure
  • Enhanced binding affinity
  • Improved specificity and stability
  • Custom analog design for difficult RNA targets
Explore Advanced Analog Chemistries →
Bio-Synthesis capability: We specialize in complex steric-blocking ASO synthesis using PNA, PMO, and TMO-related chemistries, with custom modification, conjugation, purification, and QC support for specialized RNA-targeting applications.

ASO Design Comparison: Gapmer vs Steric-Blocking vs Splice-Switching

This comparison helps users choose the right antisense oligonucleotide strategy based on whether the desired outcome is RNA degradation, functional blocking, or splice modulation.

Feature Gapmer ASO Steric-Blocking ASO Splice-Switching ASO
Primary Mechanism RNase H-mediated RNA degradation Physical blocking of RNA function Modulation of pre-mRNA splicing
RNA Cleavage Yes No No
Typical Structure DNA gap + modified wings Fully modified oligonucleotide Fully modified oligonucleotide
Common Chemistries PS, DNA gap, LNA, cEt, 2′-MOE PNA, PMO, TMO, 2′-OMe, 2′-MOE, LNA PMO, 2′-OMe, 2′-MOE, LNA, TMO analogs
Primary Applications Gene knockdown and mRNA degradation Translation blocking, miRNA inhibition, RNA-protein blocking Exon skipping, exon inclusion, transcript engineering
Target Location mRNA in cytoplasm and nucleus mRNA, miRNA, or regulatory RNA Pre-mRNA in nucleus
Advantages High potency through catalytic degradation High specificity without RNA cleavage Precise control of transcript structure
Limitations Potential off-target cleavage if not optimized Requires strong binding affinity and accessible target site Requires accurate splice-site targeting
Best Use Case Reduce gene expression Block function without destroying RNA Modify gene expression at the splicing level
Design guidance: Gapmer ASOs are selected for RNA knockdown, while steric-blocking and splice-switching ASOs are used when RNA function or transcript structure must be modulated without degradation.

Advanced ASO Chemistry Comparison

The table below summarizes commonly requested and advanced ASO chemistry options. Bio-Synthesis supports a broader portfolio of base, sugar, backbone, linkage, terminal, and conjugation modifications beyond those listed here.

Chemistry / Modification Type Key Advantages Best Applications Notes
Phosphorothioate (PS) Backbone Nuclease resistance, improved stability, enhanced protein binding Standard ASO designs across mechanisms Industry-standard backbone
2′-O-Methyl (2′-OMe) Sugar Improves stability, binding affinity, and nuclease resistance Steric-blocking ASO, splice-switching ASO, antimiR Common non-cleaving chemistry
2′-MOE Sugar High affinity, good nuclease resistance, broad therapeutic use Gapmer wings, steric-blocking ASO, miRNA inhibition Balanced potency and safety profile
2′-Fluoro (2′-F) Sugar Increased duplex stability and nuclease resistance Hybrid ASO designs and RNA-targeting applications Useful in mixed-modification designs
LNA / BNA Bridged sugar Very high affinity, improved specificity, shorter designs All ASO types, high-potency targeting Strong binding; placement matters
cEt (Constrained Ethyl) Sugar analog LNA-like affinity, improved manufacturability, strong potency Advanced gapmer and therapeutic-style ASO designs Next-generation LNA alternative
PNA Backbone analog Neutral backbone, extremely high affinity, resistant to enzymes Steric-blocking, diagnostics, research Does not activate RNase H
PMO / Morpholino Backbone analog Neutral backbone, high stability, no RNase H activation Steric-blocking and splice-switching Gold standard for splice modulation
TMO / Tricyclo-DNA Constrained analog Enhanced affinity, structural rigidity, improved specificity Steric-blocking and specialized RNA targets Advanced analog platform
Stereopure PS ASO Backbone optimization Defined chirality, improved potency, reduced off-target effects High-potency therapeutic development Next-generation backbone control
GalNAc Conjugate Conjugate Liver-targeting delivery, enhanced uptake, lower dose potential Liver disease and metabolic targets Clinically validated delivery strategy
Peptide Conjugate Conjugate Improved cell penetration, tissue targeting, versatile delivery Extrahepatic delivery, oncology, CNS research Flexible targeting option
Cholesterol / Lipid Conjugate Conjugate Enhanced membrane uptake, improved PK profile, tissue distribution Systemic delivery and preclinical studies Can improve potency and exposure

Need a specialized ASO chemistry?
This table highlights common and advanced chemistries only. Bio-Synthesis supports additional exotic base, sugar, backbone, linkage, and conjugation modifications. Contact us or request a quote for custom steric-blocking ASO synthesis.

Typical Applications of Steric-Blocking ASOs

Steric-blocking ASOs provide precise, non-cleaving control of RNA function, enabling broad applications in therapeutic development, functional genomics, and advanced molecular research.

Typical applications of steric-blocking antisense oligonucleotides including translation blocking, RNA-protein inhibition, splice modulation, gene expression modulation, and diagnostics

Custom Synthesis Options

Bio-Synthesis offers flexible steric-blocking ASO synthesis tailored to discovery, translational, and development-stage projects.

Design & Chemistry

  • PNA, PMO, TMO / Tricyclo-DNA analog support
  • Fully modified non-cleaving ASO designs
  • Backbone, sugar, base, linkage, terminal, and conjugation modifications
  • Advanced chemistry support for difficult RNA targets

Scale & Purification

  • Research to development-scale synthesis
  • Project support up to 100 g/batch
  • HPLC and PAGE purification options
  • Salt exchange, desalting, and lyophilization support

Quality Control

  • Mass spectrometry confirmation
  • Analytical HPLC
  • OD260 quantification
  • Custom release testing upon request

Quality System Support

  • ISO 9001:2015 / ISO 13485:2016
  • GLP/GMP-aligned project support
  • U.S.A. facilities in Texas
  • 45+ years of oligonucleotide expertise

Optional Add-On Services

Custom Formulation & Packaging →

Buffers, aliquoting, concentrations, tubes or plates, OEM labels/barcodes.

Custom Quality Control →

LC-MS, CE, extended HPLC traces, endotoxin/bioburden, water content, residual chemical analysis, stability program.

Regulatory & OEM →

RUO→GLP→cGMP pathways, document packages, tech transfer, and sequence masking.

Contact & Quote Request

For the fastest review, send your target sequence, desired mechanism, chemistry preference, scale, purification, QC requirements, and any conjugation or delivery needs.

Fast quote checklist

  • Target gene/transcript and species
  • Desired mechanism: translation blocking, splice modulation, miRNA inhibition, or RNA-protein blocking
  • Preferred chemistry: PNA, PMO, TMO, LNA, 2′-OMe, 2′-MOE, or custom
  • Scale, purity, and QC requirements
  • Conjugation, labeling, or documentation needs

Fastest path

Request a Quote Speak to a Scientist

FAQ

What is a steric-blocking ASO?
A steric-blocking ASO is a fully modified antisense oligonucleotide that binds RNA without recruiting RNase H, enabling functional RNA control without transcript cleavage.
Which chemistries are used for steric-blocking ASOs?
Common chemistries include PNA, PMO, TMO / Tricyclo-DNA analogs, 2′-OMe, 2′-MOE, LNA, BNA, cEt, and related fully modified ASO designs.
Is PMO used for splice-switching?
Yes. PMO is widely used for steric-blocking and splice-switching applications, including exon skipping and splice-site modulation.
Does Bio-Synthesis support advanced ASO modifications?
Yes. Bio-Synthesis supports a broad portfolio of standard, advanced, and custom ASO chemistries including backbone, sugar, base, linkage, terminal, and conjugation modifications.
More FAQ'sAll FAQ's

Scientific Validation & Recommended Reading

Steric-blocking antisense oligonucleotide technologies are supported by peer-reviewed literature covering splice modulation, non-cleaving RNA targeting, PMO and PNA chemistry, RNA-protein interaction blocking, and therapeutic antisense oligonucleotide development.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links